0 CHECKOUT

PRODUCT FILTERS

REGION

5
2
2
2
1

COUNTRY

2
1

CATEGORIES

  • 8
  • 1
  • 1
  • 1
  • 1

PRICE

6
8
8
11

PUBLISHED

0
1
7
11

PRODUCT TYPE

4
3
2
1
1

Search for: "Salix Pharmaceuticals, Ltd.-Deals & Alliances Report"

Salix Pharmaceuticals Ltd. (SLXP) - Financial and Strategic SWOT Analysis Review

Salix Pharmaceuticals Ltd. (SLXP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

Published:  April 2015
Price:  From

Salix Pharmaceuticals, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

The Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization...

Published:  March 2016
Price:  From

Inflammatory Bowel Disease Therapeutics - Global Strategic Business Report

This report analyzes the Global market for Inflammatory Bowel Disease Therapeutics in US$ Million Annual estimates and forecasts are provided for the period 2006 through 2015 The report profiles 69...

Published:  April 2010
Price:  From

Global Biosimilars Market, 2015 - 2025

Characterised by increased utility in chronic diseases and capital intensive manufacturing, the global biopharmaceutical market is expanding robustly. As the demand for biologics is increasing continuously,...

Published:  July 2015
Price:  From

Eisai Inc. - Strategic SWOT Analysis Review

Eisai Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis,...

Published:  June 2015
Price:  From

Prescription Drugs - Global Strategic Business Report

This report analyzes the worldwide markets for Prescription Drugs in US$ Billion by the following therapeutic class – Oncologics/ Cancer Drugs, Lipid Regulators, Respiratory Agents, Proton Pump Inhibitors,...

Published:  July 2009
Price:  From

Eisai Co., Ltd. - Product Pipeline Review - H2 2011

Eisai Co., Ltd. – Product Pipeline Review – H2 2011 Summary Global Market Direct’s pharmaceuticals report, “Eisai Co., Ltd. - Product Pipeline Review - H2 2011” provides data on the Eisai Co., Ltd.’s...

Published:  November 2011
Price:  From

North American Corporate Rating Scores By Industry Sector As Of March 5, 2015 May 15

Abstract Standard & Poor's Ratings Services is updating the rating component scores for its public corporate credit ratings in North America. This article follows a similar report published on Feb....

Published:  May 2015
Price: 

Asia-Pacific And Latin America Amassed Debt At A Far Faster Pace Than Europe And North America, Says S&P Report Jan 16

Abstract MELBOURNE (Standard & Poor's) Jan. 14, 2016-Debt growth in Asia-Pacific and Latin America has outstripped the regions' GDP expansion during 2009-2015 at a far faster pace than that in Europe...

Published:  January 2016
Price: 

Negative Outlooks On Global Corporates Exceed Positive Ones By The Widest Margin Since 2009, Says S&P Report Jan 16

Abstract MELBOURNE (Standard & Poor's) Jan. 12, 2016--The net outlook bias is a negative 11%, which is the worst level since the 2008-2009 financial crisis. That's according to a report by Standard...

Published:  January 2016
Price: 

Global Corporate Debt Demand Declines To $57 Trillion As Credit Risk Concentrates In China, U.S. Jul 15

Abstract MELBOURNE (Standard & Poor's) July 16, 2015--Global corporate debt demand will peak at an estimated $57 trillion by 2019, a decline of 4% from last year's projection, according to an annual...

Published:  July 2015
Price: 
Loading Indicator

Our Clients

  • Procter & Gamble Co.
  • Johnson & Johnson Services, Inc.
  • Bayer AG
  • Bugaboo International B.V.
  • Svenska Cellulosa Aktiebolaget SCA
  • Kimberly-Clark Corporation
  • Medela